Sentence examples for benefit of this class from inspiring English sources

We show the benefit of this class of suggested devices in one particular structure, a zero-¯n gap superlattice, for the sake of comparison with the recently reported structures.

Because studies indicate GIP has minimal effects in type 2 diabetes, most of the therapeutic benefit of this class has been ascribed to the actions of GLP-1.

Antibodies directed against the epidermal growth factor (EGF) receptor family initially showed the benefit of this class of molecules for cancer therapy [ 10].

Post hoc subgroup analyses conducted for several fibrate monotherapy trials, including the Helsinki Heart Study, which had a positive overall result (26), support the potential benefit of this class of drugs in individuals with significant baseline dyslipidemia (18, 27).

The real benefit of this class of tests is their ability to be taken by large numbers of candidates with minimal cost in terms of finance and medical school faculty time.

This may support the use of taxanes in these subsets of patients, even when node-negative, but additional researches are warranted in order to better predict a specific therapeutic benefit of this class of drugs according to the tumor features.

Given the rich content of amide groups, we hypothesize that our polyamides could have similar amide cluster-induced luminescence, which could bring additional benefits of this class of materials.

The problem with the Death-by-Xanax headlines, then, is that not only are they misleading, but that they also confuse the public, simultaneously obscuring the benefits of this class of sedatives and their more serious dangers: their addictiveness.

1– 3 Key demonstrated benefits of this class of agents are reduced glycosylated hemoglobin, reduced postprandial glucose (and fasting glucose depending on duration of action), lowered body weight, and a low incidence of hypoglycemia (without concomitant sulfonylurea use).

The troglitazone experience, with the idiosyncratic side effect of liver damage considered along with the multiple potential benefits of this class, is important to note "because we've come full circle" to realizing the TZD class effect of reducing liver fat, with preliminary evidence of improvement in nonalcoholic steatohepatitis.

Despite the lowering of plasma glucose, significant hypoglycemia is not demonstrated with GLP-1 RAs secondary to the glucose-dependent mechanism, which is considered a benefit to this class of medications.